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An early report warned that people with intellectual and 
developmental disabilities (IDD) may be at higher risk during 
the COVID-19 pandemic.1 Three reasons for concern were 
proposed. First, people with IDD are a socially disadvantaged 
population that experiences comparatively higher levels of 
health disparities2,3 that may be aggravated during the 
pandemic. Additionally, people with IDD have a higher 
prevalence of pneumonia, a respiratory infection initially 
identified as possibly leading to more severe COVID-19 
outcomes.4 Finally, a disproportionate percentage of the IDD population resides in congregate settings,5 presenting 
increased challenges to physically distance and reduce the spread of the virus.6 Results from early studies confirmed 
the concern that COVID-19 presents a more severe risk to people with IDD. In a study analyzing real-time electronic 
medical data of those with COVID-19, people with IDD had a higher prevalence of co-occurring medical conditions 
associated with more severe COVID-19 outcomes and higher case-fatality rates. Those conditions included 
respiratory, endocrine, nutritional, metabolic, and circulatory diseases.7 A second study reported higher COVID-19 
case rate, case-fatality rate, and mortality rate among a sample of adults with IDD that lived in Medicaid waiver funded 
residential group homes in New York State.8 
 
In response to these early concerning results, a research team from Syracuse University and Upstate Medical 
University is collaborating with New York Disabilities Advocates (NYDA), a coalition of organizations that serve and 
support people with IDD in New York State, to track COVID-19 outcomes among this population over time. This 
report compares COVID-19 trends among 13,200 adults with IDD living in Medicaid waiver funded residential 






For people with IDD living in residential group 
homes in New York State, COVID-19: 
• Case rates were consistently 3.4 times 
higher than for New York State as of late 
April 2020. 
• Case growth rates were similar to those of 
New York State as of May 2020. 
• Case-fatality rates were consistently 1.9 
times higher than for NY State as of late 
April 2020. 





While COVID-19 case rates increased between April 10, 2020 and July 10, 2020 for both groups, from April 10 to 
May 1, the case rate increased by 2.5 times for people with IDD, from 2,225 to 5,544 cases per 100,000, but only 
increased by 1.6 times for New York State, from 886 to 1,584 cases per 100,000. From May 1 to July 10, the case 
rate increased for both groups at a similar rate, 1.3 times. 
 
Figure 1. Case Rate People with Intellectual and Developmental Disability (IDD) and New York 
State Overall 
Data Source: New York Disabilities Advocates (NYDA) COVID-19 Survey of Providers; Johns Hopkins’ Center for 
Systems Science and Engineering COVID-19 Tracker 
 
Case Growth Rates 
Analysis of the case growth rate reveals a similar pattern. The rate of week over week growth in cases was higher for 
people with IDD (54%) than for New York State (34%) on April 17. However, there was a more substantial decrease 
in the case growth rate for people with IDD through early May, resulting in a similar growth rate for people with IDD 
(6%) and New York State (7%) by May 8. From May 15 through July 3, the case growth rate steadily declined for 
both groups from approximately 4% to 1%. 
 
Figure 2. Case Growth Rate for People with Intellectual and Developmental Disability (IDD) and 
New York State Overall 
Data Source:   New York Disabilities Advocates (NYDA) COVID-19 Survey of Providers; Johns Hopkins’ Center 
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Case-fatality rates (the percentage of confirmed COVID-19 cases that resulted in death) were 2.7 times higher for 
people with IDD (19%) than for New York State overall (7%) on April 10. The case-fatality rate then dropped but 
remained approximately 2.0 times higher for people with IDD (~16%) than for New York State overall (8%) from 
April 17 to July 10. 
 
Figure 3. Case-fatality Rate for People with Intellectual and Developmental Disability (IDD) and 
New York State Overall 
Data Source:  New York Disabilities Advocates (NYDA) COVID-19 Survey of Providers; Johns Hopkins’ Center for 
Systems Science and Engineering COVID-19 Tracker 
 
A Call for Increased Monitoring and Data Sharing 
Trends in this report show that while the growth in diagnosed cases of COVID-19 among adults with IDD initially 
outpaced the growth of cases in New York State overall, a shift occurred in early May. From May through early July 
the two groups experienced a similar pattern in cases. Although there was a slight reduction in the case-fatality rate 
among people with IDD in early April, case-fatality rates remained around two times higher for people with IDD from 
mid-April to early July. 
 
There are a couple of plausible explanations for the differences in cases in the early part of this study. People with IDD 
have not historically, nor during this pandemic, been granted the same priority for health care afforded to the general 
population.9 This disparity has been most obvious as residential group homes for people with IDD were not 
prioritized for testing at the same level as nursing homes. The marked increase in cases observed from early April to 
early May might reflect this lack of prioritization and delayed access to testing for people with IDD. 
 
The differences observed in confirmed cases in the early part of this study may also reflect the positive effects of 
policies enacted by the group home providers and by New York State.10 For instance, by mid-March, policies were in 
place to ensure that group home residents did not participate in community-related outings or day programs, and 
outside visitors were no longer allowed in group homes. By early April, policies were in place requiring COVID-19 
positive residents to quarantine and residential group home employees were required to wear facemasks. Reduction in 
the growth of cases among people with IDD from mid-April to early May possibly resulted from policies like these 
attempting to protect residents and contain the spread of the virus. 
 
While it is promising that trends in COVID-19 cases for people with IDD were in line with those of New York State 
by early May, the persistently higher case-fatality rate calls for further investigation. To date, there is not sufficient data 
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4 
existing health conditions among this population. Continued collection and reporting of robust data are crucial in 
identifying the factors that contribute to poorer outcomes for people with IDD, as well as in further monitoring of this 
particularly vulnerable population. 
 
Data and Methods 
Data for people with IDD living in residential group homes are from the New York Disabilities Advocates (NYDA) 
COVID-19 Survey of Providers. Data for New York State are from the Johns Hopkins’ Center for Systems Science 
and Engineering COVID-19 data github. Case rate was calculated as (number of cases/number served) * 100,000. 
Case growth rate was calculated as a three-week rolling average. Case-fatality rate was calculated as the number of 
deaths/number of cases. 
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